文献速递消化道肿瘤与早癌消化内镜

结直肠癌无创筛查的新兴检测方法

Emerging Tests for Noninvasive Colorectal Cancer Screening.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-12-17

本文综述当前结直肠癌筛查方法,并讨论基于血浆循环肿瘤DNA、血清蛋白、粪便DNA或mRNA及肠道微生物组分析的新兴无创筛查检测的原理及支持其临床潜力的数据。美国癌症协会估计结直肠癌将导致六十分之一的美国人死亡,建议所有45岁及以上美国人接受筛查。

要点

  • 结直肠癌筛查推荐用于所有45岁及以上美国人。
  • 当前筛查方法有效且可降低结直肠癌相关死亡率,但尚无理想检测且依从性不足。
  • 新兴无创检测基于分子生物学、遗传学和表观遗传学进展,包括血液、粪便和微生物组方法。

核心结论

  • 新兴结直肠癌无创筛查检测基于分子生物学、遗传学和表观遗传学进展,旨在解决当前筛查检测的不足。

研究设计与样本

  • 综述,回顾当前筛查方法并讨论最有前景的新兴结直肠癌筛查检测的原理及支持其临床潜力的数据。

主要发现

  • 新兴检测包括使用血浆循环肿瘤DNA和血清蛋白检测早期结直肠癌和进展期腺瘤的血液检测、使用粪便DNA或mRNA的检测以及肠道微生物组分析方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Colorectal cancer (CRC) is among the most common cancers globally and a major cause of cancer-related deaths. The American Cancer Society estimates that CRC will kill 1 in 60 Americans, and CRC screening is recommended for all Americans ≥45 years of age. Current CRC screening methods are effective for preventing CRC and have been shown to reduce CRC-related mortality. However, none of the currently available tests is ideal, and many people are not compliant with screening recommendations. Novel screening tests based on advances in CRC molecular biology, genetics, and epigenetics, combined with developments in sequencing technologies and computational analytic methods, have been developed to address the shortcomings of current CRC screening tests. These emerging tests include blood-based assays that use plasma-derived circulating tumor DNA and serum proteins to detect early CRC and advanced adenomas, assays that use stool DNA or mRNA, and methods for profiling the gut microbiome. Here we review current screening modalities, and we discuss the principles behind the most promising emerging CRC screening tests and the data supporting their potential to be used in clinical practice.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Hanna M, Dey N, Grady WM, et al. Emerging Tests for Noninvasive Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2022. PMID: 36539002. doi:10.1016/j.cgh.2022.12.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。